{"entity":{"type":"insider","cik":"0001281668","url":"/insider/0001281668","json_url":"/insider/0001281668.json","name":"ORBIMED CAPITAL GP II LLC","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":12,"n_filings":6,"first":"2005-07-18","last":"2013-02-14","span_basis":"filed_date"},"name_variants":[{"name":"ORBIMED CAPITAL GP II LLC","source":"filing","n_filings":3,"first_seen":"2012-05-08","last_seen":"2013-02-14"},{"name":"ORBIMED CAPITAL II LLC","source":"filing","n_filings":3,"first_seen":"2005-07-18","last_seen":"2006-06-02"}],"transactions":[{"id":4516527,"accession":"0000947871-13-000121","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000947871-13-000121","line_url":"/filing/0000947871-13-000121","is_derivative":false,"issuer_cik":"0001055949","issuer_name":"SUPERNUS PHARMACEUTICALS INC","issuer_ticker":"SUPN","issuer_name_source":null,"issuer_url":"/issuer/0001055949","owner_cik":null,"owner_name":"ORBIMED CAPITAL GP II LLC; ORBIMED ADVISORS LLC; ISALY SAMUEL D","owner_display_name":"ORBIMED CAPITAL GP II LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":150000.0,"shares_display":"150,000","price_per_share":7.5757,"price_display":"7.58","price_state":"stated","total_value":1136355.0,"total_display":"1,136,355.00","total_whole":"1,136,355","shares_owned_after":2183000.0,"shares_owned_after_display":"2,183,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-02-13","filed_date":"2013-02-14","scope":"insider","n_lines":2},{"id":4516520,"accession":"0000947871-13-000121","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000947871-13-000121","line_url":"/filing/0000947871-13-000121","is_derivative":false,"issuer_cik":"0001055949","issuer_name":"SUPERNUS PHARMACEUTICALS INC","issuer_ticker":"SUPN","issuer_name_source":null,"issuer_url":"/issuer/0001055949","owner_cik":null,"owner_name":"ORBIMED CAPITAL GP II LLC; ORBIMED ADVISORS LLC; ISALY SAMUEL D","owner_display_name":"ORBIMED CAPITAL GP II LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":152183.0,"shares_display":"152,183","price_per_share":7.5218,"price_display":"7.52","price_state":"stated","total_value":1144690.0894,"total_display":"1,144,690.09","total_whole":"1,144,690","shares_owned_after":2291900.0,"shares_owned_after_display":"2,291,900","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-02-12","filed_date":"2013-02-14","scope":"insider","n_lines":2},{"id":2441976,"accession":"0000947871-12-000779","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000947871-12-000779","line_url":"/filing/0000947871-12-000779#line-2","is_derivative":false,"issuer_cik":"0001055949","issuer_name":"SUPERNUS PHARMACEUTICALS INC","issuer_ticker":"SUPN","issuer_name_source":null,"issuer_url":"/issuer/0001055949","owner_cik":null,"owner_name":"ISALY SAMUEL D; ORBIMED CAPITAL GP II LLC; ORBIMED ADVISORS LLC","owner_display_name":"ISALY SAMUEL D","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":7.0767,"price_display":"7.08","price_state":"stated","total_value":707670.0,"total_display":"707,670.00","total_whole":"707,670","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-12-18","filed_date":"2012-12-19","scope":"insider"},{"id":2441969,"accession":"0000947871-12-000779","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-12-000779","line_url":"/filing/0000947871-12-000779#line-1","is_derivative":false,"issuer_cik":"0001055949","issuer_name":"SUPERNUS PHARMACEUTICALS INC","issuer_ticker":"SUPN","issuer_name_source":null,"issuer_url":"/issuer/0001055949","owner_cik":null,"owner_name":"ISALY SAMUEL D; ORBIMED CAPITAL GP II LLC; ORBIMED ADVISORS LLC","owner_display_name":"ISALY SAMUEL D","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":197815.0,"shares_display":"197,815","price_per_share":6.8479,"price_display":"6.85","price_state":"stated","total_value":1354617.3385,"total_display":"1,354,617.34","total_whole":"1,354,617","shares_owned_after":100000.0,"shares_owned_after_display":"100,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-12-17","filed_date":"2012-12-19","scope":"insider"},{"id":3539589,"accession":"0000947871-12-000426","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000947871-12-000426","line_url":"/filing/0000947871-12-000426","is_derivative":false,"issuer_cik":"0001055949","issuer_name":"SUPERNUS PHARMACEUTICALS INC","issuer_ticker":"SUPN","issuer_name_source":null,"issuer_url":"/issuer/0001055949","owner_cik":null,"owner_name":"ISALY SAMUEL D; ORBIMED CAPITAL GP II LLC; ORBIMED ADVISORS LLC","owner_display_name":"ISALY SAMUEL D","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1100000.0,"shares_display":"1,100,000","price_per_share":5.0,"price_display":"5.00","price_state":"stated","total_value":5500000.0,"total_display":"5,500,000.00","total_whole":"5,500,000","shares_owned_after":2402600.0,"shares_owned_after_display":"2,402,600","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-05-04","filed_date":"2012-05-08","scope":"insider","n_lines":3},{"id":2800159,"accession":"0000947871-06-001038","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-06-001038","line_url":"/filing/0000947871-06-001038#line-1","is_derivative":false,"issuer_cik":"0000858803","issuer_name":"AVANIR PHARMACEUTICALS","issuer_ticker":"AVN","issuer_name_source":null,"issuer_url":"/issuer/0000858803","owner_cik":null,"owner_name":"ORBIMED ADVISORS LLC; ISALY SAMUEL D; ORBIMED CAPITAL II LLC","owner_display_name":"ORBIMED ADVISORS LLC","owner_url":null,"role":"Director","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":629121.0,"shares_display":"629,121","price_per_share":9.79,"price_display":"9.79","price_state":"stated","total_value":6159094.59,"total_display":"6,159,094.59","total_whole":"6,159,095","shares_owned_after":1706137.0,"shares_owned_after_display":"1,706,137","ownership_form":"I","is_10b5_1":null,"transaction_date":"2006-05-31","filed_date":"2006-06-02","scope":"insider"},{"id":3638638,"accession":"0000947871-06-001019","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-06-001019","line_url":"/filing/0000947871-06-001019#line-1","is_derivative":false,"issuer_cik":"0001055949","issuer_name":"GIVEN IMAGING LTD","issuer_ticker":"GIVN","issuer_name_source":null,"issuer_url":"/issuer/0001055949","owner_cik":null,"owner_name":"ORBIMED CAPITAL LLC; ORBIMED CAPITAL II LLC; ORBIMED ADVISORS LLC; ISALY SAMUEL D","owner_display_name":"ORBIMED CAPITAL LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22500.0,"shares_display":"22,500","price_per_share":18.14,"price_display":"18.14","price_state":"stated","total_value":408150.0,"total_display":"408,150.00","total_whole":"408,150","shares_owned_after":3610402.0,"shares_owned_after_display":"3,610,402","ownership_form":"I","is_10b5_1":null,"transaction_date":"2006-05-24","filed_date":"2006-05-26","scope":"insider"},{"id":1407132,"accession":"0000947871-05-001368","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-05-001368","line_url":"/filing/0000947871-05-001368#line-1","is_derivative":false,"issuer_cik":"0001055949","issuer_name":"CRYOCOR INC","issuer_ticker":"CRYO","issuer_name_source":null,"issuer_url":"/issuer/0001055949","owner_cik":null,"owner_name":"ORBIMED ADVISORS LLC; ISALY SAMUEL D; ORBIMED CAPITAL II LLC","owner_display_name":"ORBIMED ADVISORS LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":135000.0,"shares_display":"135,000","price_per_share":11.0,"price_display":"11.00","price_state":"stated","total_value":1485000.0,"total_display":"1,485,000.00","total_whole":"1,485,000","shares_owned_after":1231936.0,"shares_owned_after_display":"1,231,936","ownership_form":"I","is_10b5_1":null,"transaction_date":"2005-07-13","filed_date":"2005-07-18","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001356576","name":"SUPERNUS PHARMACEUTICALS INC","url":"/issuer/0001356576","role":"Director, Ten percent owner","n_filings":3,"first_seen":"2012-05-08","last_seen":"2013-02-14"},{"type":"issuer","type_label":"ISSUER","cik":"0000858803","name":"AVANIR PHARMACEUTICALS","url":"/issuer/0000858803","role":"Director","n_filings":1,"first_seen":"2006-06-02","last_seen":"2006-06-02"},{"type":"issuer","type_label":"ISSUER","cik":"0001126140","name":"GIVEN IMAGING LTD","url":"/issuer/0001126140","role":"Director, Ten percent owner","n_filings":1,"first_seen":"2006-05-26","last_seen":"2006-05-26"},{"type":"issuer","type_label":"ISSUER","cik":"0001125294","name":"CRYOCOR INC","url":"/issuer/0001125294","role":"Director, Ten percent owner","n_filings":1,"first_seen":"2005-07-18","last_seen":"2005-07-18"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001281668","retrieved_at":"2026-08-25T04:58:23+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}